Stacie Halbert

Stacie Halbert has extensive work experience in the pharmaceutical industry. Stacie started their career at GSK in 1993 as an Associate Investigator, where they were involved in the design, synthesis, and characterization of novel drug candidates. Stacie then progressed to the role of Project Manager and later became a Team Leader/Project Director. Stacie joined PAREXEL in 2015 as a Project Director before returning to GSK as a Project Director in Project Planning and Management. In 2021, they joined Nimbus Therapeutics as a Senior Project Director, and they were subsequently promoted to Executive Director and currently holds the position of Vice President, Program Management and R&D Strategic Operations.

Stacie Halbert completed their education in the field of Organic Chemistry. Stacie obtained their Bachelor of Science (B.S.) degree from William & Mary in 1992, followed by a Master of Science (M.S.) degree also from William & Mary in 1993. In addition to their academic achievements, they obtained a Project Management Professional (PMP) certification from the Project Management Institute (PMI) in January 2003.